Venous Leg Ulcer Treatment Market Report 2025

The venous leg ulcer treatment market size has grown strongly in recent years. It will grow from $4.0 billion in 2024 to $4.3 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period can be attributed to the rising prevalence of venous leg ulcers, greater awareness of advanced wound care therapies, increasing preference for minimally invasive treatments, the expanded use of antimicrobial dressings, and the growing adoption of bioengineered skin substitutes.

The venous leg ulcer treatment market size is expected to see strong growth in the next few years. It will grow to $5.68 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The projected growth during the forecast period can be attributed to rising healthcare expenditures, increased research and development efforts, a growing number of diabetes cases, higher demand for compression therapy products, and the expanding need for personalized wound care solutions. Key trends expected in this period include advancements in wound dressings, innovations in compression therapy, the integration of telemedicine, the use of artificial intelligence (AI) for wound assessment, and the expansion of health insurance coverage.

The expansion of healthcare facilities is expected to drive the growth of the venous leg ulcer treatment market. Healthcare facilities encompass the essential physical infrastructure, systems, and resources required to provide effective medical services. The growth of healthcare infrastructure is primarily driven by advancements in medical technology, as innovations such as telemedicine, robotic surgery, and AI-driven diagnostics necessitate upgraded facilities, specialized equipment, and improved healthcare delivery systems to enhance patient care and efficiency. These healthcare facilities play a crucial role in venous leg ulcer treatment by ensuring access to modern wound care technologies, evidence-based therapies, skilled medical professionals, and innovative treatment options, all of which contribute to better healing outcomes and an improved quality of life for patients. For example, according to the American Hospital Association, a US-based non-profit organization, the total number of hospitals in the United States reached 6,120 in 2024, increasing from 6,093 in 2022. As a result, the ongoing expansion of healthcare infrastructure is fueling the growth of the venous leg ulcer treatment market.

Leading companies in the venous leg ulcer treatment market are developing advanced wound dressings utilizing biosynthetic cellulose to improve healing and enhance chronic wound management. Biosynthetic cellulose is a bioengineered material produced by microorganisms through fermentation, offering high purity, biocompatibility, and excellent structural integrity for various medical applications. For instance, in June 2023, Evonik Industries AG, a Germany-based specialty chemicals company, introduced Epicite Balance, a wound dressing made from biosynthetic cellulose designed for the treatment of chronic wounds such as venous leg ulcers, diabetic foot ulcers, and pressure ulcers. This dressing supports wound healing by maintaining a moist wound environment, absorbing exudate, and facilitating superior cleansing, making it suitable for both hospital and homecare use.

In June 2022, Healiva SA, a Switzerland-based company specializing in comprehensive chronic wound care solutions, acquired two wound-healing cell therapy assets from Smith+Nephew plc for an undisclosed amount. This acquisition allowed Healiva SA to enhance its portfolio by integrating advanced cell therapy solutions for chronic wound care. Smith+Nephew plc, a UK-based medical technology company, provides venous leg ulcer treatment solutions.

Major players in the venous leg ulcer treatment market are 3M Healthcare, Essity AB, B. Braun Melsungen AG, Smith & Nephew plc, Coloplast A/S, Convatec Group PLC, Molnlycke Healthcare, Integra LifeSciences, Hollister Incorporated, Bioventus LLC, Medi, Kerecis, HSE.ie, Tissue Regenix Group, The Whiteley Clinic, Huntleigh Healthcare, Derma Sciences, Systagenix Wound Management, Kinetic Concepts, and Orpyx Medical Technologies.

North America was the largest region in the venous leg ulcer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in venous leg ulcer treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the venous leg ulcer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Venous leg ulcer treatment encompasses a comprehensive approach to managing and healing open sores that develop on the legs due to poor venous circulation. This treatment typically includes compression therapy to enhance blood flow, wound care to prevent infections, and medical or lifestyle interventions to address underlying venous conditions.

The primary treatment methods for venous leg ulcers include compression therapy, debridement, medication, and surgery. Compression therapy is a non-invasive approach that applies pressure to the affected leg to improve circulation, reduce swelling, and promote healing while preventing recurrence. The condition can stem from various etiologies, including venous insufficiency, arterial insufficiency, and mixed insufficiency. Treatment mechanisms involve oxygenation enhancers, growth factor stimulators, anti-inflammatory agents, and antimicrobial therapies. These treatments are utilized across various settings, including hospitals, clinics, home healthcare, and other medical facilities.

The venous leg ulcer treatment market research report is one of a series of new reports that provides venous leg ulcer treatment market statistics, including venous leg ulcer treatment industry global market size, regional shares, competitors with a venous leg ulcer treatment market share, detailed venous leg ulcer treatment market segments, market trends and opportunities, and any further data you may need to thrive in the venous leg ulcer treatment industry. This venous leg ulcer treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The venous leg ulcer treatment market consists of revenues earned by entities by providing services such as infection management, and skin grafting. The market value includes the value of related goods sold by the service provider or included within the service offering. The venous leg ulcer treatment market also includes sales of compression stockings, foam dressings, skin protectants, debridement tools, and hydrocolloid dressings. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.